Riskpilot← Back to searchSign inGet full accessLivio Falun AB
ABDissolvedOrg 5567432629Medical specialists activities · NACE 8622Est. 20070 employees
Revenue 2024
SEK 25,9M
+3% vs 2023
EBITDA margin
14.3%
+59% vs 2023
Equity ratio
19.9%
Financial strength
Net profit 2024
SEK -24K
+94% vs 2023
| Revenue | SEK 25,9M | +3% |
| EBITDA | SEK 3,7M | +59% |
| Net profit | SEK -24K | +94% |
| Total assets | SEK 8,1M | -34% |
| Equity | SEK 1,6M | -1% |
| Employees | 0 | — |
Legal name
Livio Falun AB
Org number
5567432629
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 november 2007
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hälso- och sjukvårdsverksamhet, forskning, utbildning och konsultverksamhet i anslutning därtill. Ävensom idka därmed förenlig verksamhet.
Address
Phone
+4623492686
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 24 331 | 22 861 | 26 281 | 25 167 | 25 888 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 971 | −1 349 | 4 321 | 2 332 | 3 709 |
| Depreciation & amort. | −578 | −428 | −418 | −459 | −294 |
| EBIT | 393 | −1 777 | 3 903 | 1 873 | 3 415 |
| Net financials | 13 | 5 | 49 | 29 | 1 |
| Profit before tax | 407 | 35 | −299 | −400 | −24 |
| Tax | −92 | −11 | −0 | −1 | −0 |
| Net profit | 315 | 24 | −299 | −401 | −24 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 903 | 6 634 | 9 961 | 12 163 | 8 062 |
| Equity | 2 305 | 2 329 | 2 030 | 1 629 | 1 606 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 117 | 3 831 | 7 511 | 10 534 | 6 457 |
| Total debt | 4 117 | 3 831 | 7 511 | 10 534 | 6 457 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20202024
Equity ratio
19.9%
This company
38.2%
Market median
-48% vs market
20202024
Return on equity
-1.5%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
3.21×
This company
1.12×
Market median
+187% vs market
20202024
Debt / equity
4.02×
This company
0.62×
Market median
-548% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PF Chief Auditor | Chief Auditor | 2024 |
EA Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
MI Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (4) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KKR GENESIS BIDCO S.L.U
Livio Falun AB Board members of Livio Falun AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Fredrik Engdahl | Chief Auditor | 0 companies |
| Magnus Ivar Thorling | Chief Auditor | 0 companies |
| Eva Anna-Carin Strandberg | Chief Executive Officer | 0 companies |
| Anna Karin Helena Lind | Deputy Board Member | 0 companies |
| Karl Henrik Hernander | Board of Directors | 0 companies |
| Björn Åke Steffan Lundberg | Deputy Board Member | 0 companies |
| Anna Karolina Anbratt | Deputy Board Member | 0 companies |
| Eugene Maxwell Marsden | Board of Directors | 0 companies |